DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acular LS (Ketorolac Tromethamine Ophthalmic) - Published Studies

 
 



Acular LS Related Published Studies

Well-designed clinical trials related to Acular LS (Ketorolac Ophthalmic)

Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. [2012]

Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery. [2011.03]

Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. [2011]

Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial. [2010.12]

Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. [2010.05]

Use of Acular LS in the pain management of keratoconus: a pilot study. [2010.02]

NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. [2010.02]

Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%. [2009.10]

Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]

Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial. [2009.02]

A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. [2008.10]

Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. [2008.09]

Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels. [2008.09]

Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]

In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. [2007.09]

Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]

Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. [2006.08]

The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial. [2006.05]

Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]

A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. [2005.07]

Well-designed clinical trials possibly related to Acular LS (Ketorolac Ophthalmic)

Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. [2010.07]

Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. [2010]

Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. [2009.08]

Comparison of topical lignocaine gel and fentanyl for perioperative analgesia in children undergoing cataract surgery. [2009.04]

Other research related to Acular LS (Ketorolac Ophthalmic)

Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis. [2014]

A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration. [2013]

Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. [2011.11.18]

Ketorolac 0.45% ophthalmic solution. [2011.07.01]

Can topical ketorolac 0.5% improve the function of Ahmed(R) glaucoma drainage devices? [2011.05]

Keratitis and corneal melt with ketorolac tromethamine after conductive keratoplasty. [2011.04]

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. [2011]

Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery. [2011]

Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF. [2010.10]

Inhibition of choroidal neovascularization by intravitreal ketorolac. [2010.05]

Use of Acular LS in the pain management of keratoconus: a pilot study. [2010]

Penetration of topically applied diclofenac and ketorolac into the aqueous humour and subretinal fluid: randomized clinical trial. [2010]

NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. [2010]

Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. [2010]

Ketorolac tromethamine formulations: an overview. [2009.09]

Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. [2009.06]

Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. [2008.11]

A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery Patients. [2008.07.01]

Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. [2008.04]

Impaired corneal wound healing associated with ketorolac 0.5% after uncomplicated extracapsular cataract extraction. [2007.12]

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. [2007.07]

Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. [2007.07]

Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. [2006.06]

[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%] [2006.04]

Pain associated with carotid artery surgery performed under carotid plexus block: preemptive analgesic effect of ketorolac. [2006.03]

Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. [2006.02]

An update on the use of ophthalmic ketorolac tromethamine 0.4%. [2006.01]

Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. [2005.11]

Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. [2005.01.25]

Other possibly related research studies

Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. [2006.02]

Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. [2006.02]

Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. [2005]

Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. [2007.02]

Nepafenac-associated corneal melt. [2007.11]

Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). [2007.11]

Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits. [2008.06]

Comparison of topical lignocaine gel and fentanyl for perioperative analgesia in children undergoing cataract surgery. [2008.12.23]

Calotropis procera -induced keratitis. [2009.01]

The effects of nepafenac and amfenac on retinal angiogenesis. [2010.02.15]

Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation. [2009.10]

Improved assessment of laser-induced choroidal neovascularization. [2010.12]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014